Showing results (81-90 of 211) with videos related to
Sort By:
Pageof 22
Neuropeptides|December 1, 1984
Electroencephalographic assessment of the role of delta receptors in opioid peptide - induced seizuresF C Tortella, L Robles, H I Mosberg, et al.European Journal of Pharmacology|December 3, 1981
Opiate-like electroencephalographic and behavioral effects of electroconvulsive shock in ratsF C Tortella, A Cowan, G L Belenky, et al.Brain Research|June 1, 1981
Dopamine partially mediates the cardiovascular effects of naloxone after spinal injuryA I Faden, T P Jacobs, G Feuerstein, et al.Peptides|July 1, 1989
Intravenous beta-endorphin: behavioral and physiological effects in conscious monkeysB N Cuthbert, J W Holaday, J Meyerhoff, et al.Annals of Emergency Medicine|June 1, 1987
Verapamil reverses calcium cardiotoxicityG P Zaloga, D Malcolm, J Holaday, et al.The Journal of Pharmacology and Experimental Therapeutics|February 1, 1993
The kappa opioid agonist U-50,488H antagonizes respiratory effects of mu opioid receptor agonists in conscious ratsK Dosaka-Akita, F C Tortella, J W Holaday, et al.Journal of the National Cancer Institute|October 8, 1999
Antiangiogenic activity of prostate-specific antigenA H Fortier, B J Nelson, D K Grella, et al.Journal of Andrology|September 1, 1984
The role of endogenous opioid peptides in the control of androgen levels in the male nonhuman primateP M Gilbeau, R G Almirez, J W Holaday, et al.Neuropeptides|December 1, 1984
ICI 174864, a putative delta opioid antagonist, reverses endotoxemic hypotension: pretreatment with dynorphin 1-13, A kappa agonist, blocks this actionJ B Long, B A Ruvio, C E Glatt, et al.The Journal of Pharmacology and Experimental Therapeutics|September 1, 1988
Neurological dysfunction after intrathecal injection of dynorphin A (1-13) in the rat. II. Nonopioid mechanisms mediate loss of motor, sensory and autonomic functionJ B Long, J M Petras, W C Mobley, et al.Pageof 22